Abstract
Recent studies indicate that right ventricular performance is impaired even in uncomplicated systemic hypertension. Because of widespread use of beta-blockade in essentially hypertension, it is possible that such treatment often further depresses right ventricular contractility. To test this premise, and to evaluate the changes induced by different beta-adrenoceptor blocking agents on the contractility of right ventricular myocardium, 20 patients with essential hypertension were divided into two groups on a double-blind randomised basis, and maintained on oral oxprenolol or propranolol for five weeks. Cardiac catheterisation and right ventricular cineangiography were performed at the beginning and again at the end of the five week period. Right ventricular end-diastolic volume index did not change significantly in either group. In contrast, right ventricular end-systolic volume index increased, and right ventricular ejection fraction significantly decreased after chronic beta-blockade. Cardiac index decreased in both groups, but these changes were not statistically significant. When the intergroup differences were compared for all measured indices none of the changes between the two groups was statistically significant. Despite its intrinsic sympathomimetic activity, oxprenolol therefore impairs right ventricular performance to an extent nearly equal to that of propranolol. Moreover, right ventricular contractility is clearly diminished after the institution of beta-blockade in hypertensive patients--an effect that has until now been thought to be limited to the left side of the heart. Great caution must therefore be exercised when beta-blockade is initiated in patients with severely abnormal right ventricular function, because frank right ventricular decompensation may result.
Full text
PDF






Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Andersson O., Berglund G., Bergman H., Cramer K., Fagerberg S. E., Forsberg S. A., Johnsen V., Lundkvist L., Rutle O., Sjolyst R. Antihypertensive effect and side-effects of treatment with beta blockers- a comparative study between oxprenolol and propranolol. Curr Ther Res Clin Exp. 1976 Jan;19(1):43–50. [PubMed] [Google Scholar]
- Aronow W. S., Ferlinz J., Del Vicario M., Moorthy K., King J., Cassidy J. Effect of timolol versus propranolol on hypertension and hemodynamics. Circulation. 1976 Jul;54(1):47–51. doi: 10.1161/01.cir.54.1.47. [DOI] [PubMed] [Google Scholar]
- Atkins J. M., Mitchell H. C., Pettinger W. A. Increased pulmonary vascular resistance with systemic hypertension. Effect of minoxidil and other antihypertensive agents. Am J Cardiol. 1977 May 26;39(6):802–807. doi: 10.1016/s0002-9149(77)80030-1. [DOI] [PubMed] [Google Scholar]
- Braunwald E. On the difference between the heart's output and its contractile state. Circulation. 1971 Feb;43(2):171–174. doi: 10.1161/01.cir.43.2.171. [DOI] [PubMed] [Google Scholar]
- Chidsey C. A., Morselli P., Bianchetti G., Morganti A., Leonetti G., Zanchetti A. Studies of the absorption and removal of propranolol in hypertensive patients during therapy. Circulation. 1975 Aug;52(2):313–318. doi: 10.1161/01.cir.52.2.313. [DOI] [PubMed] [Google Scholar]
- Coltart D. J. Comparison of effects of propranolol and practolol on exercise tolerance in angina pectoris. Br Heart J. 1971 Jan;33(1):62–64. doi: 10.1136/hrt.33.1.62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Coltart J., Alderman E. L., Robison S. C., Harrison D. C. Effect of propranolol on left ventricular function, segmental wall motion, and diastolic pressure-volume relation in man. Br Heart J. 1975 Apr;37(4):357–364. doi: 10.1136/hrt.37.4.357. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Conolly M. E., Kersting F., Dollery C. T. The clinical pharmacology of beta-adrenoceptor-blocking drugs. Prog Cardiovasc Dis. 1976 Nov-Dec;19(3):203–234. doi: 10.1016/0033-0620(76)90016-5. [DOI] [PubMed] [Google Scholar]
- Degen P. H., Riess W. Simplified method for the determination of oxprenolol and other beta-receptor-blocking agents in biological fluids by gas-liquid chromatography. J Chromatogr. 1976 Jun 9;121(1):72–75. doi: 10.1016/s0021-9673(00)82299-2. [DOI] [PubMed] [Google Scholar]
- Di Biase M., Guglielmi R., Scarcia A., Chiddo A., Rizzon P. Electrophysiologic properties of intravenous oxprenolol in man. J Electrocardiol. 1977 Jul;10(3):267–273. doi: 10.1016/s0022-0736(77)80069-1. [DOI] [PubMed] [Google Scholar]
- Dollery C. T., George C. Propranolol--ten years from introduction. Cardiovasc Clin. 1974;6(2):255–268. [PubMed] [Google Scholar]
- Dollery C. T., Paterson J. W., Conolly M. E. Clinical pharmacology of beta-receptor-blocking drugs. Clin Pharmacol Ther. 1969 Nov-Dec;10(6):765–799. [PubMed] [Google Scholar]
- Dwyer E. M., Jr, Wiener L., Cox J. W. Effects of beta-adrenergic blockade (propranolol) on left ventricular hemodynamics and the electrocardiogram during exercise-induced angina pectoris. Circulation. 1968 Aug;38(2):250–260. doi: 10.1161/01.cir.38.2.250. [DOI] [PubMed] [Google Scholar]
- Ferlinz J., Easthope J. L., Hughes D., Siegel J., Tobis J., Aronow W. S. Antihypertensive and hemodynamic effects of oxprenolol versus propranolol. Clin Pharmacol Ther. 1980 Jun;27(6):733–743. doi: 10.1038/clpt.1980.104. [DOI] [PubMed] [Google Scholar]
- Ferlinz J. Measurements of right ventricular volumes in man from single plane cineangiograms. A comparison to the biplane approach. Am Heart J. 1977 Jul;94(1):87–90. doi: 10.1016/s0002-8703(77)80348-7. [DOI] [PubMed] [Google Scholar]
- Ferlinz J. Right ventricular performance in essential hypertension. Circulation. 1980 Jan;61(1):156–162. doi: 10.1161/01.cir.61.1.156. [DOI] [PubMed] [Google Scholar]
- Fitzgerald J. D. Perspectives in adrenergic beta-receptor blockade. Clin Pharmacol Ther. 1969 May-Jun;10(3):292–306. doi: 10.1002/cpt1969103292. [DOI] [PubMed] [Google Scholar]
- Frishman W., Smithen C., Befler B., Kligfield P., Killip T. Noninvasive assessment of clinical response to oral propranolol therapy. Am J Cardiol. 1975 May;35(5):635–644. doi: 10.1016/0002-9149(75)90049-1. [DOI] [PubMed] [Google Scholar]
- Goldstein R. E., Hall C. A., Epstein S. E. Comparison of relative inotropic and chronotropic effects of propranolol, practolol, and sotalol. Chest. 1973 Nov;64(5):619–627. doi: 10.1378/chest.64.5.619. [DOI] [PubMed] [Google Scholar]
- Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
- Helfant R. H., Herman M. V. Abnormalities of left ventricular contraction induced by beta adrenergic blockade. Circulation. 1971 May;43(5):641–647. doi: 10.1161/01.cir.43.5.641. [DOI] [PubMed] [Google Scholar]
- Kreulen T. H., Bove A. A., McDonough M. T., Sands M. J., Spann J. F. The evaluation of left ventricular function in man. A comparison of methods. Circulation. 1975 Apr;51(4):677–688. doi: 10.1161/01.cir.51.4.677. [DOI] [PubMed] [Google Scholar]
- Lecerof H., Malmborg R. O. Hemodynamic effects of oxprenolol alone and combined with nitroglycerin in patients with ischemic heart disease. Acta Med Scand. 1972 Dec;192(6):499–506. doi: 10.1111/j.0954-6820.1972.tb04854.x. [DOI] [PubMed] [Google Scholar]
- Ludbrook P., Karliner J. S., Kostuk W., O'Rourke R. A. Effects of intravenously administered propranolol on wall motion abnormalities. Am J Cardiol. 1973 Jun;31(6):712–717. doi: 10.1016/0002-9149(73)90005-2. [DOI] [PubMed] [Google Scholar]
- Majid P. A., Sharma B., Saxton C., Stoker J. B., Taylor S. H. Haemodynamic effects of oxprenolol in hypertensive patients. Postgrad Med J. 1970 Nov;(Suppl):67–72. [PubMed] [Google Scholar]
- Marshall A. J., Barritt D. W. Oxprenolol in hypertension. Br J Clin Pract. 1973 Sep;27(9):337–340. [PubMed] [Google Scholar]
- Mason W. D., Winer N. Pharmacokinetics of oxprenolol in normal subjects. Clin Pharmacol Ther. 1976 Oct;20(4):401–412. doi: 10.1002/cpt1976204401. [DOI] [PubMed] [Google Scholar]
- McDevitt D. G., Brown H. C., Carruthers S. G., Shanks R. G. Influence of intrinsic sympathomimetic activity and cardioselectivity on beta adrenoceptor blockade. Clin Pharmacol Ther. 1977 May;21(5):556–566. doi: 10.1002/cpt1977215556. [DOI] [PubMed] [Google Scholar]
- Nayler W. G. Myocardial function during beta-adrenergic blockade. Isr J Med Sci. 1969 Jul-Aug;5(4):741–746. [PubMed] [Google Scholar]
- New units for old. Br Heart J. 1975 Jan;37(1):1–1. [PMC free article] [PubMed] [Google Scholar]
- Nies A. S., Shand D. G. Clinical pharmacology of propranolol. Circulation. 1975 Jul;52(1):6–15. doi: 10.1161/01.cir.52.1.6. [DOI] [PubMed] [Google Scholar]
- Olivari M. T., Fiorentini C., Polese A., Guazzi M. D. Pulmonary hemodynamics and right ventricular function in hypertension. Circulation. 1978 Jun;57(6):1185–1190. doi: 10.1161/01.cir.57.6.1185. [DOI] [PubMed] [Google Scholar]
- Prichard B. N., Aellig W. H., Richardson G. A. The action of intravenous oxprenolol, practolol, propranolol and sotalol on acute exercise tolerance in angina pectoris: the effect on heart rate and the electrocardiogram. Postgrad Med J. 1970 Nov;(Suppl):77–85. [PubMed] [Google Scholar]
- Rackley C. E. Quantitative evaluation of left ventricular function by radiographic techniques. Circulation. 1976 Dec;54(6):862–879. doi: 10.1161/01.cir.54.6.862. [DOI] [PubMed] [Google Scholar]
- Robson R. H., Fluck D. C. Autonomic blockade and coronary catecholamines and cyclic AMP in exercising man. J Appl Physiol Respir Environ Exerc Physiol. 1977 Dec;43(6):949–952. doi: 10.1152/jappl.1977.43.6.949. [DOI] [PubMed] [Google Scholar]
- Shubrooks S. J., Jr, Zir L. M., Dinsmore R. E., Harthorne J. W. Left ventricular wall motion response to intravenous propranolol. Circulation. 1975 Jul;52(1):124–129. doi: 10.1161/01.cir.52.1.124. [DOI] [PubMed] [Google Scholar]
- Sniderman A. D., Marpole D. G., Fallen E. L. Differences between the effects of practolol and propranolol on the diastolic properties of the left ventricle. Clin Pharmacol Ther. 1977 Mar;21(3):267–271. doi: 10.1002/cpt1977213267. [DOI] [PubMed] [Google Scholar]
- Stephens J., Hayward R., Ead H., Adams L., Hamer J., Spurrell R. Effects of selective and non-selective beta-adrenergic blockade on coronary dynamics in man assessed by rapid atrial pacing. Br Heart J. 1978 Aug;40(8):856–863. doi: 10.1136/hrt.40.8.856. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Turner G. G., Nelson R. R., Nordstrom L. A., Diefenthal H. C., Gobel F. L. Comparative effect of nadolol and propranolol on exercise tolerance in patients with angina pectoris. Br Heart J. 1978 Dec;40(12):1361–1370. doi: 10.1136/hrt.40.12.1361. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Vervloet E., Pluym B. F., Cilissen J., Köhlen K., Merkus F. W. Propranolol serum levels during twenty-four hours. Clin Pharmacol Ther. 1977 Dec;22(6):853–857. doi: 10.1002/cpt1977226853. [DOI] [PubMed] [Google Scholar]
- Waal-Manning H. J. Atenolol and three nonselective beta-blockers in hypertension. Clin Pharmacol Ther. 1979 Jan;25(1):8–18. doi: 10.1002/cpt19792518. [DOI] [PubMed] [Google Scholar]
- Walle T., Conradi E. C., Walle U. K., Fagan T. C., Gaffney T. E. The predictable relationship between plasma levels and dose during chronic propranolol therapy. Clin Pharmacol Ther. 1978 Dec;24(6):668–677. doi: 10.1002/cpt1978246668. [DOI] [PubMed] [Google Scholar]
- Wolfson S., Gorlin R. Cardiovascular pharmacology of propranolol in man. Circulation. 1969 Oct;40(4):501–511. doi: 10.1161/01.cir.40.4.501. [DOI] [PubMed] [Google Scholar]
- Yin F. C., Raizes G. S., Guarnieri T., Spurgeon H. A., Lakatta E. G., Fortuin N. J., Weisfeldt M. L. Age-associated decrease in ventricular response to haemodynamic stress during beta-adrenergic blockade. Br Heart J. 1978 Dec;40(12):1349–1355. doi: 10.1136/hrt.40.12.1349. [DOI] [PMC free article] [PubMed] [Google Scholar]
